X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13979) 13979
Publication (1435) 1435
Book Review (201) 201
Book Chapter (162) 162
Conference Proceeding (44) 44
Dissertation (26) 26
Reference (6) 6
Book / eBook (4) 4
Data Set (3) 3
Magazine Article (3) 3
Newspaper Article (2) 2
Web Resource (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
glucagon-like peptide-1 (9026) 9026
index medicus (8018) 8018
humans (7470) 7470
animals (6050) 6050
male (4815) 4815
endocrinology & metabolism (4538) 4538
diabetes (2960) 2960
glucose (2911) 2911
female (2790) 2790
type 2 diabetes (2755) 2755
glucagon (2689) 2689
insulin (2689) 2689
diabetes mellitus, type 2 - drug therapy (2525) 2525
rats (2446) 2446
glucagon-like peptide 1 (2445) 2445
mice (2310) 2310
glp-1 (2259) 2259
obesity (1923) 1923
hypoglycemic agents - therapeutic use (1860) 1860
peptides (1812) 1812
pharmacology & pharmacy (1780) 1780
middle aged (1769) 1769
blood glucose - metabolism (1698) 1698
adult (1686) 1686
glucagon-like peptide-1 receptor (1633) 1633
insulin - metabolism (1598) 1598
secretion (1451) 1451
glucagon-like peptide 1 - metabolism (1422) 1422
liraglutide (1328) 1328
diabetes mellitus (1313) 1313
insulin secretion (1268) 1268
physiological aspects (1246) 1246
insulin - blood (1236) 1236
research (1228) 1228
glycemic control (1224) 1224
biochemistry & molecular biology (1183) 1183
physiology (1177) 1177
dextrose (1154) 1154
analysis (1136) 1136
insulin resistance (1089) 1089
hypoglycemic agents - pharmacology (1068) 1068
exenatide (1064) 1064
food-intake (1059) 1059
diabetes mellitus, type 2 - metabolism (1003) 1003
glucagon-like peptide 1 - blood (997) 997
aged (991) 991
digestive, oral, and skin physiology (960) 960
peptides - pharmacology (956) 956
diabetes mellitus, type 2 - blood (927) 927
metabolism (916) 916
health aspects (904) 904
insulin-secretion (904) 904
expression (881) 881
type-2 diabetes-mellitus (875) 875
glucagon-like peptide 1 - analogs & derivatives (872) 872
blood glucose - drug effects (858) 858
beta-cell function (845) 845
treatment outcome (840) 840
endocrine system (837) 837
abridged index medicus (836) 836
glucose metabolism (836) 836
gastric-inhibitory polypeptide (834) 834
nutrition & dietetics (827) 827
glucagon-like peptide 1 - pharmacology (820) 820
care and treatment (818) 818
exendin-4 (815) 815
rodents (809) 809
receptor (800) 800
internal medicine (799) 799
incretin (798) 798
article (768) 768
glucose - metabolism (766) 766
hyperglycemia (765) 765
mice, inbred c57bl (752) 752
medicine & public health (742) 742
hypoglycemic agents - administration & dosage (739) 739
rats, sprague-dawley (720) 720
hormones, hormone substitutes, and hormone antagonists (715) 715
risk factors (715) 715
medicine, research & experimental (700) 700
metformin (698) 698
body weight (697) 697
insulin-resistance (696) 696
receptors, glucagon - agonists (692) 692
glucose tolerance test (682) 682
venoms - pharmacology (679) 679
hormones (677) 677
glucagon-like peptide 1 - therapeutic use (675) 675
insulin-secreting cells - metabolism (673) 673
receptors, glucagon - metabolism (673) 673
double-blind (672) 672
peptide fragments - pharmacology (667) 667
hypoglycemic agents (666) 666
neurosciences (654) 654
dipeptidyl-peptidase iv inhibitors - therapeutic use (652) 652
rats, wistar (638) 638
body-weight (621) 621
hypoglycemic agents - adverse effects (615) 615
cell biology (611) 611
glucagon-like peptide-1 receptor - agonists (609) 609
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13604) 13604
German (94) 94
Japanese (72) 72
Spanish (67) 67
Chinese (66) 66
French (56) 56
Korean (32) 32
Italian (30) 30
Russian (15) 15
Czech (9) 9
Hungarian (9) 9
Polish (9) 9
Danish (8) 8
Turkish (5) 5
Portuguese (4) 4
Swedish (3) 3
Slovenian (2) 2
Croatian (1) 1
Dutch (1) 1
Icelandic (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CELL JOURNAL, ISSN 2228-5806, 2020, Volume 21, Issue 4, pp. 371 - 378
Objective: Glucagon-like peptide-1 (GLP-1) has attracted tremendous attention for treatment of diabetes. Likewise, it seems that active ingredients of... 
TEA | Chamomile Oil | IN-VITRO | ANTIOXIDANT | BETA-CELL | MICE | Differentiation | Glucagon-Like Peptide-1 | Mesenchymal Stem cells | Insulin-Producing Cells | CELL BIOLOGY | Mesenchymal Stem Cell
Journal Article
Progress in Neuropsychopharmacology & Biological Psychiatry, ISSN 0278-5846, 12/2019, Volume 95, p. 109720
Epidemiological and mechanistic studies support the association between Diabetes and mood disorders, such as Major Depressive Disorder and Bipolar Disorder.... 
Type 2 diabetes Mellitus | Bipolar disorder | Anti-hyperglycemic agents | Insulin | Major depressive disorder | METFORMIN | GLYCEMIC CONTROL | INTRANASAL INSULIN | DOMAIN CRITERIA RDOC | PSYCHIATRY | NIMH RESEARCH | DEPRESSIVE SYMPTOMS | MELLITUS | NEUROSCIENCES | CLINICAL NEUROLOGY | COGNITIVE DECLINE | GLUCAGON-LIKE PEPTIDE-1 | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY
Journal Article
Artificial Cells, Nanomedicine, and Biotechnology, ISSN 2169-1401, 12/2019, Volume 47, Issue 1, pp. 2325 - 2332
Increased free fatty acids (FFA) are one of the risk factors for type 2 diabetes. FFA also contribute to endothelial dysfunction in both the prediabetes and... 
Free fatty acids (FFA) | NF-κB | lixisenatide | endothelial dysfunction | HUVECs | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | CELL DYSFUNCTION | PREVENTS | ENDOTHELIAL FUNCTION | NF-kappa B | GLUCAGON-LIKE PEPTIDE-1 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GLUCOSE | EXPRESSION
Journal Article
by Widjaja, J and Dolo, PR and Zhang, Q and Yao, LB and Li, C and Hong, J and Wang, H and Meng, S and Shao, Y and Zhu, XC
SCIENTIFIC REPORTS, ISSN 2045-2322, 07/2019, Volume 9, Issue 1, pp. 9981 - 7
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 12/2019, Volume 120, p. 109537
Journal Article
by Luo, J and Sun, P and Siwko, T and Liu, MY and Xiao, JR
BONE RESEARCH, ISSN 2095-4700, 07/2019, Volume 7, Issue 1, pp. 1 - 19
Journal Article
by Xie, YA and Wang, YZ and Ding, HY and Guo, M and Wang, X and Dong, Q and Cui, M
JOURNAL OF NEUROINFLAMMATION, ISSN 1742-2094, 04/2019, Volume 16, Issue 1, pp. 72 - 14
Background: Diabetes is known to be a main risk factor of post-stroke hemorrhagic transformation following recombinant tissue plasminogen activator (rt-PA)... 
TISSUE-PLASMINOGEN ACTIVATOR | PROGNOSIS | Glycosylation | Ischemic stroke | MODEL | INDUCTION | IMMUNOLOGY | NEUROSCIENCES | VASCULAR PROTECTION | Blood-brain barrier | ALTEPLASE | Glucagon-like peptide-1 receptor agonist | ACUTE ISCHEMIC-STROKE | THROMBOLYSIS | Diabetes | CD147 | BRAIN-BARRIER BREAKDOWN | CAVEOLIN-1 | RNA, Small Interfering - genetics | Diabetes Mellitus, Experimental - drug therapy | Rats, Wistar | Blood-Brain Barrier - physiopathology | Male | Glial Fibrillary Acidic Protein - metabolism | Glycosylation - drug effects | Occludin - metabolism | Tissue Plasminogen Activator - adverse effects | Matrix Metalloproteinase 9 - metabolism | Reperfusion | Infarction, Middle Cerebral Artery - complications | Hemorrhage - etiology | Diabetes Mellitus, Experimental - complications | Disease Models, Animal | Collagen Type IV - metabolism | Astrocytes - drug effects | Brain - cytology | Matrix Metalloproteinase 2 - metabolism | Cells, Cultured | Caveolin 1 - genetics | Rats | Infarction, Middle Cerebral Artery - pathology | Caveolin 1 - metabolism | Animals | Basigin - metabolism | Diabetes Mellitus, Experimental - pathology | Endothelial Cells - drug effects | Caveolin-1 | Diabetic retinopathy | Transformation | Glucagon | Membrane permeability | Tunicamycin | Systematic review | CD147 antigen | Matrix metalloproteinase | Hemorrhage | t-Plasminogen activator | Cell adhesion & migration | Hyperglycemia | Ischemia | Cerebral blood flow | Rodents | Hemoglobin | Extracellular matrix | Metalloproteinase | Glucagon-like peptide 1 | Stroke | Advanced glycosylation end products | Therapeutic applications | Astrocytes | Caveolin | Diabetes mellitus | Permeability | Endothelial cells | Endothelium | Agonists | Veins & arteries
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 2375 - 6
We aimed to assess if GLP-1 agonists are associated with pancreatic cancer. Systematic review and meta-analysis of randomized trials with GLP-1 agonists as an... 
THERAPY | LIRAGLUTIDE | MULTIDISCIPLINARY SCIENCES | ENDOCRINE | EXENATIDE | RATS | NO EVIDENCE | RISK | EXOCRINE PANCREAS | Clinical trials | Systematic review | Glucagon | Glucagon-like peptide 1 | Pancreatic cancer
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 04/2019, Volume 9, Issue 1, pp. 6156 - 11
Journal Article
Journal of Nanobiotechnology, ISSN 1477-3155, 01/2019, Volume 17, Issue 1, pp. 19 - 12
BackgroundProtein-based Cas9 in vivo gene editing therapeutics have practical limitations owing to their instability and low efficacy. To overcome these... 
CRISPR-Cas system | Type 2 diabetes mellitus | Nanoliposome | Dipeptidyl peptidase-4 gene | EFFICIENT DELIVERY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | HUMAN-CELLS | GLUCOSE | CRISPR-CAS9 | NANOSCIENCE & NANOTECHNOLOGY | MELLITUS | GENOME | Lecithins - administration & dosage | Cell Line | Gene Targeting | Dipeptidyl Peptidase 4 - metabolism | RNA, Guide - genetics | Liposomes - administration & dosage | Humans | Dipeptidyl Peptidase 4 - genetics | Glucagon-Like Peptide 1 - blood | Gene Editing | Drug Delivery Systems | Mice, Knockout | Blood Glucose - drug effects | Liposomes - chemistry | Animals | Lecithins - chemistry | RNA, Guide - chemistry | CRISPR-Cas Systems | Diabetes Mellitus, Type 2 - therapy | RNA, Guide - administration & dosage | Mice | Genetic Therapy - methods | Type 2 diabetes | Care and treatment | Physiological aspects | Genetic aspects | Research | Liposomes | Properties | Self assembly | Enzyme activity | Lecithin | Peptides | Glucagon | Liver | Lipids | Genomes | Glucose | Proteins | Enzymatic activity | Efficiency | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Genetic modification | Deoxyribonucleic acid--DNA | CRISPR | Enzymes | Liver diseases | Peptidase | Stability | Kidneys | Diabetes mellitus | Gene expression | Ribonucleic acid--RNA | Insulin | Organic chemistry | Self-assembly | Insulin resistance | Diabetes
Journal Article